GASTALDON, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 843
EU - Europa 797
AS - Asia 282
OC - Oceania 4
AF - Africa 2
SA - Sud America 1
Totale 1.929
Nazione #
US - Stati Uniti d'America 834
GB - Regno Unito 228
CN - Cina 221
IT - Italia 172
IE - Irlanda 103
SE - Svezia 97
FR - Francia 87
VN - Vietnam 42
DE - Germania 41
FI - Finlandia 36
UA - Ucraina 12
CA - Canada 8
ES - Italia 5
IN - India 5
NL - Olanda 5
KR - Corea 3
AU - Australia 2
BE - Belgio 2
ET - Etiopia 2
HK - Hong Kong 2
HU - Ungheria 2
JP - Giappone 2
NZ - Nuova Zelanda 2
RO - Romania 2
TR - Turchia 2
AR - Argentina 1
AT - Austria 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
GR - Grecia 1
IQ - Iraq 1
LA - Repubblica Popolare Democratica del Laos 1
MY - Malesia 1
PA - Panama 1
PK - Pakistan 1
PT - Portogallo 1
SG - Singapore 1
Totale 1.929
Città #
Southend 219
Chandler 201
Dublin 94
Ashburn 85
Beijing 61
Jacksonville 55
Woodbridge 51
New York 49
Lawrence 38
Princeton 38
Verona 35
Wilmington 27
Houston 21
Helsinki 20
Jinan 20
Sindelfingen 19
Dong Ket 18
Nanjing 14
Washington 14
Redwood City 13
Milan 11
Dearborn 10
Shenyang 10
Seattle 9
Changsha 8
Rome 8
Turin 8
Guangzhou 7
Haikou 7
Nanchang 7
Zhengzhou 7
Norwalk 6
Redmond 6
Fairfield 5
Jiaxing 5
Lappeenranta 5
Taizhou 5
Tianjin 5
Toronto 5
Cagliari 4
Clifton Park 4
Hebei 4
Isola della Scala 4
Marano di Napoli 4
Taiyuan 4
Aosta 3
Bologna 3
Chions 3
Mungia 3
Ningbo 3
Omaha 3
Pieve di Soligo 3
San Francisco 3
Seoul 3
Addis Ababa 2
Amsterdam 2
Ancona 2
Buffalo 2
Calcinaia 2
Castellarano 2
Catania 2
Catanzaro 2
Chicago 2
Columbus 2
Eger 2
Esslingen am Neckar 2
Fiano Romano 2
Fuzhou 2
Hangzhou 2
Hong Kong 2
Kochi 2
Los Angeles 2
Magenta 2
Mumbai 2
Ottawa 2
Rho 2
San Giovanni Lupatoto 2
Santa Giustina 2
Tucson 2
Vila-real 2
Adelaide 1
Alexandria 1
Andover 1
Ann Arbor 1
Athens 1
Atlanta 1
Auckland 1
Baltimore 1
Bovolone 1
Brno 1
Brussels 1
Buenos Aires 1
Cambridge 1
Caserta 1
Changle 1
Chengdu 1
Clearwater 1
Constanța 1
Dongguan 1
Dueville 1
Totale 1.349
Nome #
Factors associated with first- versus second-generation long-acting antipsychotics prescribed under ordinary clinical practice in Italy 88
Come reagiscono al trauma i bambini sfollati? Un’analisi esplorativa degli studi condotti in contesti di guerra. [Displaced versus non-displaced children in war contexts: An explorative analysis of psychological reactions to war experiences] 87
Drug dose as mediator of treatment effect in antidepressant drug trials: the case of fluoxetine 84
Maintenance treatment with long-acting injectable antipsychotics for people with nonaffective psychoses: a network meta-analysis 78
Paroxetine versus other anti-depressive agents for depression 73
Benzodiazepines and risk of dementia: true association or reverse causation? 72
Antipsychotic drug exposure and risk of myocardial infarction 71
Focused psychosocial interventions for children in low-resource humanitarian settings: a systematic review and individual participant data meta-analysis 71
Efficacy and acceptability of antidepressants in patients with ischemic heart disease: systematic review and meta-analysis 68
Are trials of psychological and psychosocial interventions for schizophrenia and psychosis included in the NICE guidelines pragmatic? A systematic review 68
Antipsychotic combinations in schizophrenia 65
Efficacy of psychosocial interventions for mental health outcomes in low-income and middle-income countries: an umbrella review 63
Esketamine for treatment resistant depression: a trick of smoke and mirrors? 62
Can a digital medicine system improve adherence to antipsychotic treatment? 60
Tolerability and efficacy of vortioxetine versus SSRIs in elderly with major depression. Study protocol of the VESPA study: a pragmatic, multicentre, open-label, parallel-group, superiority, randomized trial 59
Fluoxetine versus other types of pharmacotherapy for depression 58
New EMA report on paliperidone 3-month injections: taking clinical and policy decisions without an adequate evidence base 52
VORTIOXETINE VERSUS SSRIs FOR THE TREATMENT OF DEPRESSION IN THE ELDERLY: A PRAGMATIC RANDOMIZED CLINICAL TRIAL 49
Antipsychotic use and risk of life-threatening medical events: umbrella review of observational studies 46
Oral and long-acting antipsychotics for relapse prevention in schizophrenia-spectrum disorders: a network meta-analysis of 92 randomized trials including 22,645 participants 46
Psychological therapies for the treatment of mental disorders in low- and middle-income countries affected by humanitarian crises 45
Effectiveness of Self-Help Plus in preventing mental disorders in refugees and asylum seekers in Western Europe: a multinational randomized controlled trial 45
Esketamine clinical trials: reply to Maju et al 43
Calling for policy actions to increase access to long-acting antipsychotics in low-income and middle-income countries 42
Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations 39
Comparative efficacy and acceptability of psychotherapies for panic disorder with or without agoraphobia: systematic review and network meta-analysis of randomised controlled trials 39
Continuing, reducing, switching, or stopping antipsychotics in individuals with schizophrenia-spectrum disorders who are clinically stable: a systematic review and network meta-analysis 37
Mediators of focused psychosocial support interventions for children in low-resource humanitarian settings: analysis from an Individual Participant Dataset with 3,143 participants 37
Long-term effectiveness of Self-Help Plus in refugees and asylum seekers resettled in Western Europe: 12-month outcomes of a randomised controlled trial 37
Pharmacological treatment of hyperactive delirium in people with COVID-19: rethinking conventional approaches 28
Post-marketing safety concerns with esketamine: a disproportionality analysis of spontaneous reports submitted to the FDA adverse event reporting system 26
Reply to the Comments by Doherty et al 24
Which psychotherapy is effective in panic disorder? And which delivery formats are supported by the evidence? Study protocol for two systematic reviews and network meta-analyses 23
A systematic review and pooled, patient-level analysis of predictors of mortality in neuroleptic malignant syndrome 22
Psychological and social interventions for the prevention of mental disorders in people living in low- and middle-income countries affected by humanitarian crises 20
Poor implementation of the EU clinical trial regulation is a major threat for pragmatic trials in European countries 19
Withdrawal syndrome following discontinuation of 28 antidepressants: pharmacovigilance analysis of 31,688 reports from the WHO spontaneous reporting database 18
CBT treatment delivery formats for panic disorder: a systematic review and network meta-analysis of randomised controlled trials 16
Polycystic ovary syndrome and postpartum depression: A systematic review and meta-analysis of observational studies 15
Risk factors of postpartum depression and depressive symptoms: umbrella review of current evidence from systematic reviews and meta-analyses of observational studies 14
Updating the WHO Model Lists of Essential Medicines to promote global access to the most cost-effective and safe medicines for mental disorders 14
Clinical trajectories of individuals with severe mental illness continuing and discontinuing long-acting antipsychotics: a one-year mirror-image analysis from the STAR Network Depot study 13
Neonatal withdrawal syndrome following in utero exposure to antidepressants: a disproportionality analysis of VigiBase, the WHO spontaneous reporting database 13
Efficacy of psychological interventions for PTSD in distinct populations - An evidence map of meta-analyses using the umbrella review methodology 12
Essential medicines for mental disorders: comparison of 121 national lists with WHO recommendations 11
Tolerability of vortioxetine compared to selective serotonin reuptake inhibitors in older adults with major depressive disorder (VESPA): a randomised, assessor-blinded and statistician-blinded, multicentre, superiority trial 10
Have the COVID-19 outbreak and related restrictions affected the right to mental health of people with severe mental health conditions? 10
Ground-breaking change to the mental health section of the WHO Model List of Essential Medicines: implications for low- and middle-income countries 5
Psychotherapies for Generalized Anxiety Disorder in Adults: A Systematic Review and Network Meta-Analysis of Randomized Clinical Trials 4
The WHO Model List of Essential Medicines for Children needs its own identity: the case of psychotropic medicines 4
Postpartum hemorrhage and postpartum depression: A systematic review and meta-analysis of observational studies 3
Esketamine for treatment-resistant depression in adults 1
Totale 2.009
Categoria #
all - tutte 8.604
article - articoli 8.439
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 165
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.208


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020180 17 2 1 0 24 26 17 10 18 25 24 16
2020/2021254 15 31 14 29 34 38 9 4 9 1 27 43
2021/2022267 13 56 5 19 24 4 9 14 12 3 33 75
2022/2023646 40 60 72 103 57 146 12 46 86 4 17 3
2023/2024435 21 44 37 51 63 117 24 40 9 20 9 0
Totale 2.009